Exane Derivatives’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-183
| Closed | -$21.5K | – | 848 |
|
|
2022
Q1 | $21.5K | Sell |
183
-370
| -67% | -$43.6K | 0.01% | 656 |
|
|
2021
Q4 | $71.6K | Sell |
553
-686
| -55% | -$88.9K | 0.02% | 464 |
|
|
2021
Q3 | $140K | Sell |
1,239
-65
| -5% | -$7.36K | 0.03% | 464 |
|
|
2021
Q2 | $139K | Sell |
1,304
-495
| -28% | -$52.8K | 0.03% | 487 |
|
|
2021
Q1 | $150K | Sell |
1,799
-883
| -33% | -$73.9K | 0.04% | 330 |
|
|
2020
Q4 | $245K | Sell |
2,682
-2,496
| -48% | -$228K | 0.07% | 274 |
|
|
2020
Q3 | $413K | Sell |
5,178
-210
| -4% | -$16.8K | 0.12% | 141 |
|
|
2020
Q2 | $372K | Buy |
5,388
+5,382
| +89,700% | +$372K | 0.1% | 166 |
|
|
2020
Q1 | $377 | Hold |
6
| – | – | ﹤0.01% | 600 |
|
|
2019
Q4 | $473 | Hold |
6
| – | – | ﹤0.01% | 586 |
|
|
2019
Q3 | $440 | Hold |
6
| – | – | ﹤0.01% | 565 |
|
|
2019
Q2 | $369 | Sell |
6
-84
| -93% | -$5.17K | ﹤0.01% | 589 |
|
|
2019
Q1 | $5.74K | Hold |
90
| – | – | ﹤0.01% | 387 |
|
|
2018
Q4 | $4.59K | Hold |
90
| – | – | ﹤0.01% | 462 |
|
|
2018
Q3 | $5.23K | Buy |
90
+9
| +11% | +$523 | ﹤0.01% | 426 |
|
|
2018
Q2 | $3.93K | Buy |
81
+15
| +23% | +$728 | ﹤0.01% | 444 |
|
|
2018
Q1 | $3.01K | Sell |
66
-3,573
| -98% | -$163K | ﹤0.01% | 412 |
|
|
2017
Q4 | $137K | Buy |
3,639
+2,883
| +381% | +$108K | 0.02% | 239 |
|
|
2017
Q3 | $27.5K | Sell |
756
-171
| -18% | -$6.23K | 0.01% | 309 |
|
|
2017
Q2 | $36.5K | Sell |
927
-42
| -4% | -$1.66K | 0.01% | 302 |
|
|
2017
Q1 | $30.4K | Buy |
+969
| New | +$30.4K | 0.01% | 276 |
|
|
2016
Q4 | – | Sell |
-2,202
| Closed | -$88.5K | – | 607 |
|
|
2016
Q3 | $88.5K | Sell |
2,202
-1,338
| -38% | -$53.8K | 0.01% | 225 |
|
|
2016
Q2 | $118K | Sell |
3,540
-72
| -2% | -$2.39K | 0.02% | 231 |
|
|
2016
Q1 | $106K | Buy |
+3,612
| New | +$106K | 0.01% | 207 |
|
|
2015
Q4 | – | Sell |
-2,070
| Closed | -$49K | – | 491 |
|
|
2015
Q3 | $49K | Buy |
+2,070
| New | +$49K | 0.01% | 230 |
|